Multiple factors, including screening using prostate specific antigen (PSA) levels, and an aging population have resulted in increased frequency of diagnosis of early stage prostate tumors, most of which do not require immediate therapeutic intervention [3]. The gene discussed is KLK3; the disease is prostate neoplasm.